These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2160362)

  • 21. Pediatric living-related liver transplantation in Saudi Arabia.
    Bassas AF; Chehab MS; Al-Shahed MS; Djurberg HG; Al-Shurafa HA; Jawdat MT; Al-Hussaini HF; Zuleika MA; Al-Hebby HA; Wali SH
    Saudi Med J; 2002 Jun; 23(6):640-4. PubMed ID: 12070539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors associated with cytomegalovirus infection in orthotopic liver transplant patients.
    Hoppe L; Marroni CA; Bressane R; Lago L; Schiavo FL; Cigerza GC; Brandão AB; Zanotelli ML; Cantisani GP
    Transplant Proc; 2006; 38(6):1922-3. PubMed ID: 16908324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection in renal transplantation. The first six months.
    Bass M
    Crit Care Nurs Clin North Am; 1990 Mar; 2(1):133-8. PubMed ID: 2357309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-transplant risk factors predicting post-transplant cytomegalovirus infection in liver transplant recipients.
    Saito T; Egawa H; Kudo T; Takakura S; Fujihara N; Iinuma Y; Ichiyama S
    Transpl Int; 2007 May; 20(5):419-24. PubMed ID: 17313448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytomegalovirus in liver transplantation: incidence and groups at risk].
    Schiffer V; Mentha G; Giostra E; Belli D; Le Coultre C; Rohner A
    Schweiz Med Wochenschr; 1994 Apr; 124(15):631-6. PubMed ID: 8191266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [BK virus infection in a pediatric renal transplant recipient].
    Bonaventura R; Vázquez A; Exeni A; Rivero K; Freire MC
    Rev Argent Microbiol; 2005; 37(3):153-5. PubMed ID: 16323666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytomegalovirus disease after liver transplantation: diagnostics and therapy.
    Wiens M; Schmidt CA; Lohmann R; Oettle H; Blumhardt G; Neuhaus P
    Transplant Proc; 1993 Aug; 25(4):2673-4. PubMed ID: 8395108
    [No Abstract]   [Full Text] [Related]  

  • 28. Laboratory evaluations of infections in immunosuppressed transplant patients.
    Ho M
    Clin Lab Med; 1991 Sep; 11(3):715-31. PubMed ID: 1657507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment with ganciclovir of disseminated cytomegalovirus infection after liver transplantation.
    Stein DS; Verano AS; Levandowski RA
    Am J Gastroenterol; 1988 Jun; 83(6):684-6. PubMed ID: 2837082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus infection in the composite liver/intestinal/pancreas allograft.
    Foster PF; Sankary HN; McChesney L; Koukoulis G; Xiao F; Kociss K; Williams JW
    Transplant Proc; 1996 Oct; 28(5):2742-3. PubMed ID: 8908034
    [No Abstract]   [Full Text] [Related]  

  • 31. Viral infections in renal transplant recipients: an evolutionary problem.
    Charpentier B
    Adv Nephrol Necker Hosp; 1986; 15():353-78. PubMed ID: 3006452
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytomegalovirus infection with perineal pain after living donor liver transplantation: report of four cases.
    Sakamoto S; Taira K; Egawa H; Takada Y
    Transpl Infect Dis; 2007 Mar; 9(1):37-41. PubMed ID: 17313470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mycobacterium kansasii infection after liver transplantation].
    Julián Gómez L; García Pajares F; Alvarez Posadilla M; Sánchez Antolín G; Velicia Llames Mdel R; Caro-Patón Gómez A
    Gastroenterol Hepatol; 2009 Apr; 32(4):283-6. PubMed ID: 19371974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The problem of cytomegalovirus infection in renal allograft recipients.
    Kurtz JB; Thompson JF; Ting A; Pinto A; Morris PJ
    Q J Med; 1984; 53(211):341-9. PubMed ID: 6091169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine).
    de Hemptinne B; Lamy ME; Salizzoni M; Cornu C; Mostin J; Fevery J; De Groote V; Otte JB
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):652-5. PubMed ID: 2831645
    [No Abstract]   [Full Text] [Related]  

  • 36. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
    Singh N; Wannstedt C; Keyes L; Wagener MM; Cacciarelli TV
    Liver Transpl; 2005 Jun; 11(6):700-4. PubMed ID: 15915496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation.
    Wiesner RH; Marin E; Porayko MK; Steers JL; Krom RA; Paya CV
    Gastroenterol Clin North Am; 1993 Jun; 22(2):351-66. PubMed ID: 8389735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The morphological consequences and the significance of cytomegalovirus infection in renal transplant patients.
    Millard PR; Herbertson BM; Nagington J; Evans DB
    Q J Med; 1973 Jul; 42(167):585-96. PubMed ID: 4353832
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship between IgM antibody to human cytomegalovirus, virus load, donor and recipient serostatus, and administration of methylprednisolone as risk factors for cytomegalovirus disease after liver transplantation.
    Emery VC; Cope AV; Sabin CA; Burroughs AK; Rolles K; Lazzarotto T; Landini MP; Brojanac S; Wise J; Maine GT
    J Infect Dis; 2000 Dec; 182(6):1610-5. PubMed ID: 11069231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors of cytomegalovirus infection after living donor liver transplantation.
    Akamatsu N; Sugawara Y; Kaneko J; Kishi Y; Makuuchi M
    Hepatogastroenterology; 2005; 52(61):197-9. PubMed ID: 15783029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.